NCT06452433 2024-06-11Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Not yet recruiting91 enrolled